Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
QuintilesIMS
Daiichi Sankyo
Boehringer Ingelheim
Fuji
AstraZeneca
Cerilliant
Colorcon

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,875,445

« Back to Dashboard

Which drugs does patent 6,875,445 protect, and when does it expire?

Patent 6,875,445 protects PHOSLO GELCAPS and is included in one NDA.
Summary for Patent: 6,875,445
Title: Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Abstract:A composition for inhibiting gastrointestinal absorption of phosphorous in an individual. The composition includes a quantity of calcium acetate sufficient to bind the phosphorous in the gastrointestinal tract of the individual. The calcium acetate has a bulk density of between 0.50 kg/L and 0.80 kg/L and is dimensioned to form a caplet for fitting within a capsule in a manner that optimizes the volume of the capsule. Also provided is a method for administering the calcium acetate composition of the present invention to an individual to reduce phosphorous absorption by binding with the phosphorous in their gastrointestinal tract.
Inventor(s): Dennett, Jr.; Edmund V. (Milton, MA), Raleigh, Jr.; Robert M. (Pembroke, MA), Aronson; Bruce H. (Sharon, MA)
Assignee: Nabi Biopharmaceuticals (Boca Raton, FL)
Application Number:10/279,598
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,875,445
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Device; Use;

Drugs Protected by US Patent 6,875,445

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Fresenius Medcl PHOSLO GELCAPS calcium acetate CAPSULE;ORAL 021160-003 Apr 2, 2001 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,875,445

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,576,665 Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Cerilliant
Express Scripts
Colorcon
Deloitte
Merck
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.